Skip to content

Perioperative Oral Vitamin D3 Supplementation on Implant Osseointegration

Efficacy of Perioperative Oral Vitamin D3 Supplementation on Implant Osseointegration in Patients With Vitamin D Deficiency

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06776640
Acronym
OSIVID
Enrollment
60
Registered
2025-01-15
Start date
2025-01-15
Completion date
2027-05-15
Last updated
2026-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implant Site Reaction

Brief summary

The number of patients treated in Implantology at Nantes University Hospital is 400 per year. This pilot study aims to demonstrate the efficacy of a 6-month oral cholecalciferol supplementation on osseointegration in patients requiring dental implants and presenting with vitamin D deficiency, compared to French patients who have not undergone vitamin D screening

Detailed description

This study will be conducted on patients with vitamin D deficiency or insufficiency who visit the Restorative and Surgical Dentistry Department at the Dental Care Center of Nantes University Hospital for implant surgery. The investigator will present the study to them and record their verbal non-opposition. Clinical data from before the surgery (approximately 3 months prior), during the surgery, and postoperative visits up to 3 months afterward will be included in the OSIVID study.

Interventions

None listed

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female patient ≥ 18 years old, candidate for dental implant placement. * with vitamin D deficiency or insufficiency: 25(OH)D \< 25 ng/L. * affiliated with a social security scheme.

Exclusion criteria

* with a local contraindication for implant placement. * under guardianship, curatorship, or legal protection * Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
The stability of the implan3 months (surgery and 3 months after)The stability of the implant measured by RFA (Resonance Frequency Analysis)

Countries

France

Contacts

CONTACTAnne-Gaelle Chaux, MD PhD
annegaelle.chaux@chu-nantes.fr02 53 48 28 35
CONTACTAlexandra Poinas, PhD
alexandra.poinas@chu-nantes.fr0253482857
PRINCIPAL_INVESTIGATORAnne-Gaelle Chaux, MD PhD

Nantes University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 25, 2026